UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 10-QSB
QUARTERLY REPORT UNDER SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For Quarter Ended: November 30, 2002 Commission File Number 000-49908
----------------- ---------
REXRAY CORPORATION
------------------------------------------------------
(Exact name of registrant as specified in its charter)
COLORADO 75-3056237
------------------------------ -------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
10077 E. County Line Road, Longmont, Colorado 80501
- --------------------------------------------- ----------
(Address of principal executive offices) (Zip code)
(303) 772-3316
----------------------------------------------------
(Registrant's telephone number, including area code)
(Former name, former address and former
fiscal year, if changed since last report.)
Indicate by check whether the registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes X No
--- ---
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Common stock, no par value 1,180,000
- -------------------------- ----------------------------
Class Number of shares outstanding
at January 13, 2003
- --------------------------------------------------------------------------------
This document is comprised of 10 pages.
- --------------------------------------------------------------------------------
INDEX
Page
----
PART 1 - FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed balance sheet, November 30, 2002 (unaudited) ......... 3
Condensed statements of operations, three and six months ended
November 30, 2002 (unaudited) and May 2, 2002 (inception)
through November 30, 2002 (unaudited) ....................... 4
Condensed statements of cash flows, six months ended
November 30, 2002 (unaudited) and May 2, 2002 (inception)
through November 30, 2002 (unaudited) ....................... 5
Notes to unaudited condensed financial statements .............. 6
Item 2. Plan of Operation ..................................... 8
PART 2 - OTHER INFORMATION
Item 1. Legal Information ..................................... 9
Item 2. Changes in Securities ................................. 9
Item 3. Defaults Upon Senior Securities ....................... 9
Item 4. Submission of Matters to a Vote of Security Holders ... 9
Item 5. Other Information ..................................... 9
Item 6. Exhibits and Reports on Form 8-K ...................... 9
Signatures ..................................................... 10
Certifications ................................................. 11
2
Part 1. Item 1. Financial Information
- ------- ---------------------
REXRAY CORPORATION
(A Development Stage Company)
Condensed Balance Sheet
(Unaudited)
November 30, 2002
Assets
Cash ............................................................... $ 138
========
Liabilities and Shareholders' Equity
Liabilities:
Accounts payable and accrued liabilities ....................... 550
--------
Total liabilities ................................ 550
--------
Shareholders' equity:
Preferred stock ................................................ --
Common stock ................................................... 11,800
Additional paid-in capital ..................................... 2,690
Deficit accumulated during development stage ................... (14,902)
--------
Total shareholder's equity ....................... (412)
--------
$ 138
========
See accompanying notes to condensed financial statements
3
REXRAY CORPORATION
(A Development Stage Company)
Condensed Statements of Operations
(Unaudited)
May 2, 2002
Three Months Six Months (Inception)
Ended Ended Through
November 30, November 30, November 30,
2002 * 2002 * 2002
----------- ----------- -----------
Operating expenses:
Stock-based compensation:
Incorporation and organization services $ -- $ -- $ 8,000
Professional fees ........................ 555 2,090 2,055
Contributed services (Note 2) ............ 1,245 2,490 1,245
Contributed rent (Note 2) ................ 200 200 200
Rent paid to related party (Note 2) ...... 100 400 200
Other .................................... 18 36 104
----------- ----------- -----------
Total operating expenses .. 2,118 5,216 11,804
----------- ----------- -----------
Loss before income taxes .. (2,118) (5,216) (11,804)
Income tax provision (Note 3) ................ -- -- --
----------- ----------- -----------
Net loss .................. $ (2,118) $ (5,216) $ (11,804)
=========== =========== ===========
Basic and diluted loss per share ............. $ (0.00) $ (0.00)
=========== ===========
Basic and diluted weighted average
common shares outstanding ................ 1,156,667 1,156,667
=========== ===========
See accompanying notes to condensed financial statements
4
REXRAY CORPORATION
(A Development Stage Company)
Condensed Statements of Cash Flows
(Unaudited)
May 2, 2002
Six Months (Inception)
Ended Through
November 30, November 30,
2002 * 2002
------- --------
Cash flows from operating activities:
Net loss ....................................................... $(5,216) $(14,902)
Adjustments to reconcile net loss to net cash
used by operating activities:
Contributed rent and services (Note 2) ................... 2,690 2,690
Common stock issued for services ......................... 200 200
Stock-based compensation ................................. -- 8,000
Changes in operating liabilities:
Accounts payable and accrued liabilities ................. 550 550
------- --------
Net cash used in
operating activities ...................... $(1,776) $ (3,462)
------- --------
Cash flows from financing activities:
Proceeds from the sale of common stock (Note 4) ................ 200 3,600
------- --------
Net cash provided by
financing activities ...................... 200 3,600
------- --------
Net change in cash ........................ (1,576) 138
Cash, beginning of period .......................................... 1,714 --
------- --------
Cash, end of period ................................................ $ 138 $ 138
======= ========
Supplemental disclosure of cash flow information:
Income taxes ................................................... $ -- $ --
======= ========
Interest ....................................................... $ -- $ --
======= ========
* The Company was incorporated on May 2, 2002; therefore, no comparative
period for the six months ended November 30, 2001 is presented.
See accompanying notes to condensed financial statements
5
REXRAY CORPORATION
(A Development Stage Company)
Notes to Unaudited Condensed Financial Statements
Note 1: Basis of Presentation
The condensed financial statements presented herein have been prepared by the
Company in accordance with the instructions for Form 10-QSB and the accounting
policies in its Form 10-SB for the period ended May 31, 2002 and should be read
in conjunction with the notes thereto.
In the opinion of management, the accompanying condensed financial statements
contain all adjustments (consisting only of normal recurring adjustments) which
are necessary to provide a fair presentation of operating results for the
interim periods presented. The results of operations presented for the three and
six months ended November 30, 2002 are not necessarily indicative of the results
to be expected for the year.
The Company is in the development stage in accordance with Statements of
Financial Accounting Standards (SFAS) No. 7 "Accounting and Reporting by
Development Stage Enterprises". As of November 30, 2002, the Company has devoted
substantially all of its efforts to financial planning and raising capital.
Financial data presented herein are unaudited.
Note 2: Related Party Transactions
The Company paid rent to Amery Coast Corporation ("ACC"), an affiliate under
common control, from May 2002 through September 2002. The office space was
valued at $100 per month based on the market rate in the local area and is
included in the accompanying financial statements as "rent paid to related
party".
During the period from October 2002 through November 2002, ACC contributed
office space to the Company. The office space was valued at $100 per month based
on the market rate in the local area and is included in the accompanying
financial statements as "contributed rent" expense with a corresponding credit
to "additional paid-in capital".
An officer contributed time and effort to the Company valued at $2,490 for the
six months ended November 30, 2002. The time and effort was valued by the
officers between $20 and $75 per hour based on the level of services performed
and is included in the accompanying condensed financial statements as
contributed services with a corresponding credit to additional paid-in capital.
Note 3: Income taxes
The Company records its income taxes in accordance with SFAS No. 109,
"Accounting for Income Taxes". The Company incurred net operating losses during
the six months ended November 30, 2002 resulting in a deferred tax asset, which
was fully allowed for; therefore, the net benefit and expense resulted in $-0-
income taxes.
6
REXRAY CORPORATION
(A Development Stage Company)
Notes to Unaudited Condensed Financial Statements
Note 4: Shareholders' Equity
During the six months ended November 30, 2002, the Company sold 20,000 shares of
its common stock for $.01 per share. The Company relied upon exemptions from
registration believed by it to be available under federal and state securities
laws in connection with the sales. The shares were sold through the Company's
officer and director. The Company received proceeds from the offering totaling
$200.
During the six months ended November 30, 2002, the Company issued 20,000 shares
of its common stock to a vendor in exchange for financial printing services. The
transaction was valued at the cost of the services rendered. The number of
shares issued was based on the contemporaneous sale of common stock to unrelated
third parties and other analysis, or $.01 per share ($200).
Following is a schedule of changes in shareholders' equity for the six months
ended November 30, 2002:
Deficit
Accumulated
Common Stock Additional During
----------------------- Paid-in Development
Shares Amount Capital Stage Total
--------- ------- ------ ------- ------
Balance June 1, 2002 .................... 1,140,000 $11,400 $ -- $(9,686) $1,714
Shares sold in private placement
offering at $.01 per share ......... 20,000 200 -- -- 200
Shares issued in exchange for
financial printing services ........ 20,000 200 -- -- 200
Services contributed by an
officer ............................ -- -- 2,490 -- 2,490
Office space contributed by an
affiliate .......................... -- -- 200 -- 200
Net loss for the six months
ended November 30, 2002 ............ -- -- -- -- --
--------- ------- ------ ------- ------
Balance, November 30, 2002 1,180,000 $11,800 $2,690 $(9,686) $4,804
========= ======= ====== ======= ======
7
Part I. Item 2. Plan of operation
- ------ -----------------
REXRAY CORPORATION
(A Development Stage Company)
PLAN OF OPERATION
The Company intends to seek out, investigate, and pursue a merger, acquisition,
or other business combination with an operating entity. There have been no
revenues from operations since inception, and none are anticipated prior to
completing a business combination.
The Company has no full-time employees, incurs nominal rent and administrative
expenses of approximately $100 per month, and has no other recurring operational
expenses except professional fees incurred as necessary. The Company's president
devotes approximately ten hours per month, without compensation, to the affairs
of the Company. Should the Company not complete a business combination within
the next three to six months, the Company plans to raise additional working
capital through the sale of its common stock. There is no assurance that the
Company will be able to raise the capital needed to maintain its development
stage operations.
The Company has no plans to acquire any assets or make any investments prior to
completing a business combination.
To date, the Company has not identified a suitable target entity for any type of
business combination, and management has no particular type of merger,
acquisition, or business opportunity in mind. No restrictions have been placed
on management's discretion to seek out and participate in an appropriate
business opportunity. Due to limited financial resources, it is anticipated that
only a single potential business venture will be pursued.
Selection of an appropriate business opportunity is complex and risky due to the
Company's limited financial resources, the speculative nature of operations,
management's limited time commitment to the Company, management's potential
conflicts of interest, the burdens of being a reporting company, lack of market
research, and competition in the marketplace. The Company's success is dependent
upon locating and consummating a business combination, and there are no
assurances that this will occur.
Special note regarding forward-looking statements
- -------------------------------------------------
This report contains forward-looking statements within the meaning of federal
securities laws. These statements plan for or anticipate the future.
Forward-looking statements include statements about our future business plans
and strategies, statements about our need for working capital, future revenues,
results of operations and most other statements that are not historical in
nature. In this Report, forward-looking statements are generally identified by
the words "intend", "plan", "believe", "expect", "estimate", and the like.
Investors are cautioned not to put undue reliance on forward-looking statements.
Except as otherwise required by applicable securities statues or regulations,
the Company disclaims any intent or obligation to update publicly these
forward-looking statements, whether as a result of new information, future
events or otherwise. Because forward-looking statements involve future risks and
uncertainties, these are factors that could cause actual results to differ
materially from those expressed or implied.
8
Part 2. Other Information
- ------ -----------------
REXRAY CORPORATION
(A Development Stage Company)
Item 1 - Legal Information.
No response required.
Item 2 - Changes in Securities.
During the six months ended November 30, 2002, the Company sold 20,000
shares of its common stock for $.01 per share. The Company relied upon
exemptions from registration believed by it to be available under
federal and state securities laws in connection with the sales. The
shares were sold through the Company's officer and director. The
Company received proceeds from the offering totaling $200.
During the six months ended November 30, 2002, the Company issued
20,000 shares of its common stock to a vendor in exchange for
financial printing services. The transaction was valued at the cost of
the services rendered. The number of shares issued was based on the
contemporaneous sale of common stock to unrelated third parties and
other analysis, or $.01 per share ($200).
Item 3 - Defaults Upon Senior Securities.
No response required.
Item 4 - Submission of Matters to a Vote of Security Holders.
No response required.
Item 5 - Other Information.
No response required.
Item 6 - Exhibits and Reports on Form 8-K.
(a) Exhibits:
1. 99.1: Certification Pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 - CEO
2. 99.2: Certification Pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 - CFO
(b) Reports on Form 8-K:
None.
9
SIGNATURES
The financial information furnished herein has not been audited by an
independent accountant; however, in the opinion of management, all adjustments
(only consisting of normal recurring accruals) necessary for a fair presentation
of the results of operations for the three and six months ended November 30,
2002 have been included.
Pursuant to the requirements of the Securities and Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
REXRAY CORPORATION
(Registrant)
DATE: January 13, 2003 BY: /s/ James B. Wiegand
---------------- ---------------------
James B. Wiegand
President
10